Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.
2.

The endocannabinoid system and extinction learning.

Lutz B.

Mol Neurobiol. 2007 Aug;36(1):92-101. Review.

PMID:
17952654
3.
4.

A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers.

de Bitencourt RM, Pamplona FA, Takahashi RN.

Neuropharmacology. 2013 Jan;64:389-95. doi: 10.1016/j.neuropharm.2012.05.039. Review.

PMID:
22687521
5.

Fear extinction and BDNF: translating animal models of PTSD to the clinic.

Andero R, Ressler KJ.

Genes Brain Behav. 2012 Jul;11(5):503-12. doi: 10.1111/j.1601-183X.2012.00801.x. Review.

6.

Extinction after retrieval: effects on the associative and nonassociative components of remote contextual fear memory.

Costanzi M, Cannas S, Saraulli D, Rossi-Arnaud C, Cestari V.

Learn Mem. 2011 Jul 15;18(8):508-18. doi: 10.1101/lm.2175811.

7.

Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care.

Jones C, Griffiths RD, Humphris G, Skirrow PM.

Crit Care Med. 2001 Mar;29(3):573-80.

PMID:
11373423
8.

Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.

Hauer D, Schelling G, Gola H, Campolongo P, Morath J, Roozendaal B, Hamuni G, Karabatsiakis A, Atsak P, Vogeser M, Kolassa IT.

PLoS One. 2013 May 7;8(5):e62741. doi: 10.1371/journal.pone.0062741.

9.

[Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders].

Lehner M, Wisłowska-Stanek A, Płaznik A.

Psychiatr Pol. 2009 Nov-Dec;43(6):639-53. Review. Polish.

PMID:
20209877
10.

The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD.

Neumeister A.

Depress Anxiety. 2013 Feb;30(2):93-6. doi: 10.1002/da.22031. No abstract available.

PMID:
23225490
11.

GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets?

Domschke K, Zwanzger P.

Curr Pharm Des. 2008;14(33):3508-17. Review.

PMID:
19075727
12.

Erratum: ERRATUM.

[No authors listed]

Indian J Anaesth. 2011 Mar;55(2):121.

13.

The endocannabinoid system in anxiety, fear memory and habituation.

Ruehle S, Rey AA, Remmers F, Lutz B.

J Psychopharmacol. 2012 Jan;26(1):23-39. doi: 10.1177/0269881111408958. Review.

14.

Traumatic memories, post-traumatic stress disorder and serum cortisol levels in long-term survivors of the acute respiratory distress syndrome.

Hauer D, Weis F, Krauseneck T, Vogeser M, Schelling G, Roozendaal B.

Brain Res. 2009 Oct 13;1293:114-20. doi: 10.1016/j.brainres.2009.04.014.

PMID:
19376097
15.

Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: a novel therapeutic approach.

de Quervain DJ, Margraf J.

Eur J Pharmacol. 2008 Apr 7;583(2-3):365-71. doi: 10.1016/j.ejphar.2007.11.068. Review.

PMID:
18275950
16.
17.

Cannabinoids modulate hippocampal memory and plasticity.

Abush H, Akirav I.

Hippocampus. 2010 Oct;20(10):1126-38. doi: 10.1002/hipo.20711.

PMID:
19830813
19.

Predicting impaired extinction of traumatic memory and elevated startle.

Nalloor R, Bunting K, Vazdarjanova A.

PLoS One. 2011;6(5):e19760. doi: 10.1371/journal.pone.0019760.

20.

Erratum: ERRATA.

[No authors listed]

Saudi J Anaesth. 2011 Oct;5(4):364.

Items per page

Supplemental Content

Support Center